anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Genelux · pitchdeck

Genelux | Investor Presentation Deck | 37 slides

37 pages · 5 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

Genelux | Investor Presentation Deck | 37 slides

Genelux · 2023-12
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON
Narrative range 12 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 2 slides 100% 2/2 slides 100% 2/2 slides · 12 hits
— 0/2 slides
— 0/2 slides
50% 1/2 slides 100% 2/2 slides
— 0/2 slides
Solution 2 slides 100% 2/2 slides 100% 2/2 slides · 9 hits
— 0/2 slides
— 0/2 slides
100% 2/2 slides 100% 2/2 slides
— 0/2 slides
Traction 6 slides 100% 6/6 slides 100% 6/6 slides · 37 hits
— 0/6 slides
50% 3/6 slides 50% 3/6 slides 100% 6/6 slides 33.3% 2/6 slides Market Size 1 slides 100% 1/1 slides 100% 1/1 slides · 6 hits
— 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides
— 0/1 slides
Team 1 slides 100% 1/1 slides 100% 1/1 slides · 7 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides

Slide inventory

37
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
other
Open slide detail
03
summarize
Open slide detail
04
The slide highlights clinical validation through trial count and patient numbers, alongside key product attributes.show_traction
Open slide detailBeat · Problem
05
The slide uses a Gantt-style visualization to show the status of multiple clinical trials.plan_implementation
Open slide detailBeat · Problem
06
Uses a process diagram to show the transition from cold to hot tumor states.present_solution
Open slide detailBeat · Solution
07
The central diagram illustrates the mechanism of action, contrasting 'Absence of Effector T Cells' (Platinum resistant) with 'Presence of Effector T Cells' (Plapresent_solution
Open slide detailBeat · Solution
08
Uses a pyramid diagram to represent the progression of clinical validation.compare_peers
Open slide detail
09
The slide compares mPFS results against SOC-AURELIA and ELAHARE benchmarks.show_traction
Open slide detailBeat · Traction
10
The slide outlines the methodology and validation of a clinical trial.show_traction
Open slide detailBeat · TractionLoop · Cost Of Inaction
11
The slide uses a table to compare clinical outcomes across patient subgroups (all, resistant, refractory) and a callout box for key takeaways.show_traction
Open slide detailBeat · TractionLoop · Cost Of Inaction
12
Waterfall plot and spider plot used to visualize clinical efficacy.show_traction
Open slide detailBeat · Traction
13
The slide uses a before-after comparison structure for three specific patient cases (15B-01, 15B-15, 15B-17).show_traction
Open slide detailBeat · Traction
14
Includes a Kaplan-Meier plot with a table comparing historical data to VIRO-15 trial results.show_traction
Open slide detailBeat · Traction
15
The slide uses a cross-trial comparison to highlight the efficacy of Olvi-Vec in heavily pre-treated patients.summarize
Open slide detailBeat · Market Size
16
The slide outlines a clinical trial protocol for Olvi-Vec in ovarian cancer.plan_implementation
Open slide detail
17
Includes Kaplan-Meier survival curves and dose escalation scatter plots for two distinct patient groups.show_traction
Open slide detail
18
Includes specific patient case reports (Pt #21A-06 and Pt #21A-04) showing tumor response metrics.show_traction
Open slide detail
19
Includes a bio for Benny Li, PhD, CEO of Newsoara.show_traction
Open slide detail
20
The slide highlights the strategic partnership and the division of commercial rights between Genelux and Newsoara.show_traction
Open slide detail
21
The slide highlights the synergy between two distinct therapeutic approaches (oncolytic immunotherapy and adoptive cell therapy).present_solution
Open slide detail
22
The slide uses a hub-and-spoke style layout to categorize strategic pillars.plan_implementation
Open slide detailLoop · Quick Win Big Bet
23
The slide uses a document-style callout for key takeaways and circular image containers for facility locations.establish_context
Open slide detailLoop · Quick Win Big Bet
24
The slide categorizes the library into therapeutic genes, immune modularity, and therapeutic antibodies.present_solution
Open slide detail
25
present_solution
Open slide detail
26
The slide uses a grid layout to present headshots, names, titles, and associated company/institution logos for each team member.other
Open slide detailBeat · Team
27
Includes specific financial metrics and analyst names.summarize
Open slide detail
28
The slide uses a dual-track timeline approach: one for executed milestones (left) and one for future goals (right).plan_implementation
Open slide detail
29
summarize
Open slide detail
30
appendix
Open slide detail
31
other
Open slide detail
32
The slide uses two distinct chart types to show longitudinal dynamics (line chart) and best response (waterfall chart) for the CA-125 biomarker.show_traction
Open slide detail
33
The slide uses a dual-axis chart to correlate tumor size (SLD) and biomarker (CA-125) response to the Olvi-Vec intervention.show_traction
Open slide detail
34
Includes histological images of patient samples (Pt.#15A-01 and Pt.#15A-11) showing tumor cell elimination and lymphocyte infiltration.show_traction
Open slide detail
35
The slide uses histology images and HALO infiltration histograms to demonstrate the mechanism of action and clinical efficacy.show_traction
Open slide detail
36
The slide uses a combination of immunological data (ELISPOT) and clinical imaging data (SLD) to show causality between immune response and tumor shrinkage.show_traction
Open slide detail
37
The slide uses clinical data (cytokine levels and PD-L1 staining) to support the mechanism of action.present_solution
Open slide detail